Peer Reviewed
Clinical case review

Shingles vaccine. Is it worth the effort?

Michael C Wehrhahn, Dominic E Dwyer
Abstract
Studies in more than 150,000 people suggest the shingles (zoster) vaccine can halve the incidence of herpes zoster and reduce its complications even more in people aged 60 years and over.
Key Points
    Case scenario

    Jessie, aged 72 years, has just returned from a holiday in the USA. During the trip she met several Americans around her age who had been given ‘shingles vaccine’ by their local doctors. They were surprised that Jessie had never heard of shingles vaccine and even more surprised that it was not promoted strongly in Australia for those aged over 65 years.

    Jessie comes to see you to ask about the vaccine and whether she should have it. She is in good health with treated stable hypertension and takes statins for hypercholesterolaemia. She says she had a severe bout of chickenpox when she was in primary school.

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?